Log in to search using one of your social media accounts:


#FDA issues updated information on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL). Know and consider the risks. https://go.usa.gov/xQxxs   #MedicalDevice

#FDA issues updated information on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL). Know and consider the risks. https://go.usa.gov/xQxxs  #MedicalDevice
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news

Related Links:

Condition:   Peripheral T Cell Lymphoma Intervention:   Biological: GB226 Sponsor:   Genor Biopharma Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Chronic Lymphocytic Leukemia;   Diffuse Large B-Cell Lymphoma;   Follicular Lymphoma;   Mantle Cell Lymphoma;   Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Intervention:   Biological: Inactivated Influenza Vaccine Sponsor:   Emory University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Authors: Marta GN, da Cunha Colombo Bonadio RR, Martins RE, Zuppani HB, de Castro G Abstract The central nervous system (CNS) is a common site of disease progression in patients with non-small-cell lung cancer (NSCLC) with anaplastic lymphoma kinase (ALK)-rearrangement treated with crizotinib. Cystic brain metastases (CBM) have been recently identified as one possible variant of this disease. An illustrative case report is presented along with a literature review performed in order to track relevant papers about CBM in ALK-rearranged NSCLC, including possible pathophysiology, differential diagnosis and treatment op...
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
In this study, we examined the impact patient travel burden has on administration of prophylactic G-CSFs and the subsequent impact on FN incidence. METHODS: Medicare claims data were used to identify a cohort of beneficiaries age 65+ with non-myeloid cancers at high risk for FN between January 2012 and December 2014. Driving distance and time were calculated from patient residence ZIP code to the location of G-CSF and/or chemotherapy administration. Regression models were used to estimate the odds of G-CSF prophylaxis relative to patient driving distance and time, and odds of FN incidence relative to timing of G-CSF ad...
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research
Authors: Aoyama Y, Tsunemine H, Zushi Y, Maruoka H, Goto Y, Kodaka T, Itoh T, Takahashi T Abstract Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a new clinical entity that was reclassified from enteropathy-associated T-cell lymphoma in the 2016 WHO classification. An 83-year-old man with fever and diarrhea was referred to our hospital because of free air in the abdominal cavity and wall thickening of the large intestine on CT. Colonofiberscopic examination revealed mucosal edema and multiple ulcers at the sigmoid colon, splenic flexure, and transverse colon. Histopathological examination of the ...
Source: Journal of Clinical and Experimental Hematopathology : JCEH - Category: Hematology Tags: J Clin Exp Hematop Source Type: research
In conclusion, CuD inhibited Akt and activated the iNOS pathway, leading to higher ROS and nitric oxide production, which accelerated gastric cancer cell apoptosis. PMID: 29658590 [PubMed - as supplied by publisher]
Source: Oncology Reports - Category: Cancer & Oncology Tags: Oncol Rep Source Type: research
In conclusion, miRNA‑23b‑3p prevents the cognitive impairment of diabetic rats via anti‑oxidative stress effects and the Sirt1/Nrf2 signaling pathway. PMID: 29658582 [PubMed - as supplied by publisher]
Source: Molecular Medicine Reports - Category: Molecular Biology Tags: Mol Med Rep Source Type: research
International Journal of Cancer, EarlyView.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research
Conclusions: The clinical features suggest that occlusion of the inferotemporal retinal arteriole prevented sub-RPE lymphomatous deposits and subsequent RPE atrophy in this area of vascular nonperfusion. This suggests that “primary” vitreoretinal lymphoma is secondary to hematogenous spread from systemic loci. This finding, together with the ocular tumor control achieved entirely by systemic therapy, indicates scope for studies investigating systemic treatment protocols, especially those including immune-modulator y agents.Ocul Oncol Pathol
Source: Ocular Oncology and Pathology - Category: Opthalmology Source Type: research
Condition:   Pediatric Hodgkin's Disease Intervention:   Radiation: No radiotherapy if CR at the end of chemotherapy. Sponsors:   Hospital JP Garrahan;   Hospital Pereyra Rosell, Montevideo, Uruguay Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Lymphoma | Medical Devices | Plastic Surgery